Catalent Inc (NASDAQ:CTLT)‘s stock had its “buy” rating reissued by analysts at Piper Jaffray Companies in a research report issued on Tuesday. They presently have a $45.00 target price on the stock. Piper Jaffray Companies’ price target indicates a potential upside of 14.30% from the company’s current price.

Several other research firms also recently weighed in on CTLT. BidaskClub downgraded Catalent from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Bank of America Corporation reaffirmed a “buy” rating and issued a $38.00 price objective (up from $37.00) on shares of Catalent in a research note on Friday, July 21st. Zacks Investment Research raised Catalent from a “hold” rating to a “buy” rating and set a $39.00 price objective for the company in a research note on Tuesday, August 22nd. Finally, William Blair raised Catalent from a “market perform” rating to an “outperform” rating in a research note on Monday, May 15th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Catalent presently has a consensus rating of “Buy” and an average price target of $35.88.

Shares of Catalent (CTLT) opened at 39.37 on Tuesday. The stock has a market capitalization of $4.93 billion and a price-to-earnings ratio of 45.25. The company has a 50-day moving average of $35.14 and a 200 day moving average of $32.37. Catalent has a 12-month low of $21.83 and a 12-month high of $40.44.

Catalent (NASDAQ:CTLT) last released its quarterly earnings data on Monday, August 28th. The company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.08. Catalent had a return on equity of 16.95% and a net margin of 4.88%. The firm had revenue of $616.90 million during the quarter, compared to the consensus estimate of $547.48 million. During the same period last year, the business posted $0.52 EPS. Catalent’s quarterly revenue was up 15.9% on a year-over-year basis. Analysts predict that Catalent will post $1.60 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Piper Jaffray Companies Reiterates Buy Rating for Catalent Inc (CTLT)” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/31/piper-jaffray-companies-reiterates-buy-rating-for-catalent-inc-ctlt.html.

In other Catalent news, SVP Christine Dolan sold 745 shares of the firm’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $34.85, for a total transaction of $25,963.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

A number of institutional investors have recently added to or reduced their stakes in CTLT. Flinton Capital Management LLC increased its position in Catalent by 17.7% in the first quarter. Flinton Capital Management LLC now owns 3,616 shares of the company’s stock valued at $102,000 after buying an additional 544 shares during the last quarter. Acrospire Investment Management LLC increased its position in Catalent by 72.2% in the second quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock valued at $109,000 after buying an additional 1,300 shares during the last quarter. Quantbot Technologies LP increased its position in Catalent by 110.7% in the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock valued at $120,000 after buying an additional 1,804 shares during the last quarter. Meadow Creek Investment Management LLC increased its position in Catalent by 17.7% in the first quarter. Meadow Creek Investment Management LLC now owns 4,972 shares of the company’s stock valued at $141,000 after buying an additional 748 shares during the last quarter. Finally, Acadian Asset Management LLC increased its position in Catalent by 115.7% in the first quarter. Acadian Asset Management LLC now owns 5,847 shares of the company’s stock valued at $166,000 after buying an additional 3,136 shares during the last quarter.

About Catalent

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Analyst Recommendations for Catalent (NASDAQ:CTLT)

Receive News & Stock Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related stocks with our FREE daily email newsletter.